Delcath Systems Inc.
Clinical trials sponsored by Delcath Systems Inc., explained in plain language.
-
New combo attack on liver tumors from colorectal cancer shows promise in early trial
Disease control Recruiting nowThis study tests whether giving a strong chemotherapy directly to the liver, followed by standard cancer pills and an injection, works better than the standard treatment alone for people whose colorectal cancer has spread mainly to the liver and hasn't responded to other treatmen…
Phase: PHASE2 • Sponsor: Delcath Systems Inc. • Aim: Disease control
Last updated May 02, 2026 12:09 UTC
-
New hope for breast cancer in the liver: targeted chemo combo enters trial
Disease control Recruiting nowThis study tests whether giving a strong chemotherapy directly to the liver, followed by standard cancer pills or infusions, works better than standard treatment alone for breast cancer that has spread mainly to the liver. About 90 adults with HER2-negative breast cancer will tak…
Phase: PHASE2 • Sponsor: Delcath Systems Inc. • Aim: Disease control
Last updated May 02, 2026 11:57 UTC